Could GLP-1s Become an Answer to Longevity?

As Head of Research & Development for the International Dermal Institute, I like to keep a close eye on medical and scientific advancements, especially those shaping the longevity space.

GLP-1 medications have become one of the biggest conversations in health and wellness, but emerging research is looking beyond weight loss. A recent study found that older female mice treated with semaglutide lived approximately 12% longer and showed improvements in physical function, cognition, glucose regulation, and markers associated with cellular aging.

There’s still a major distinction to make: these findings are in mice, and we don’t yet know whether the same longevity effects translate to humans. But for skin professionals, it raises an interesting bigger-picture question as the industry continues to explore skin longevity and whole-body aging:

Do you think GLP-1 medications will eventually become part of the wider longevity conversation, not just the weight-loss conversation?

Read the full article here: GLP-1 Weight-Loss Drugs Can Slow Aging and Extend Life Span, Mouse Study Suggests